Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma |
Stanford University / Julien Sage, PhD |
Innovation Grants |
2018 |
California |
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research / Andrew Napper |
Innovation Grants |
2010 |
Delaware |
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia |
Boston Children’s Hospital / Alan Cantor, MD, PhD |
Innovation Grants |
2015 |
Massachusetts |
Choline Kinase and Alkylating Agent Resistance in Refractory Childhood Leukemias |
Boston Children’s Hospital / Alejandro Gutierrez, MD |
Innovation Grants |
2021 |
Massachusetts |
Investigating the role of lin-28 in germ cell tumorigenesis
|
Boston Children’s Hospital / George Daley |
Innovation Grants |
2009 |
Massachusetts |
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital / Alan B. Cantor, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Investigating the Role of Lin-28 in Germ Cell Tumorigenesis |
Boston Children’s Hospital / George Daley, MD/PhD |
Innovation Grants |
2011 |
Massachusetts |
GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death |
Boston Children’s Hospital / Dr. Ben Croker, PhD |
Innovation Grants |
2016 |
Massachusetts |